Is there a role for targeted therapies in the collecting ducts of Bellini carcinoma? Efficacy data from a retrospective analysis of 7 cases

Clinical and Experimental Nephrology

Volumn 16, Issue 3, 2012, Pages 464-467

  Procopio, Giuseppe ^a   Verzoni, Elena ^a   Iacovelli, Roberto ^b   Colecchia, Maurizio ^a   Torelli, Tullio ^a   Mariani, Luigi ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Collecting ducts carcinoma (CDC); Nephrectomy; Renal cell carcinoma (RCC); Sorafenib; Sunitinib; Targeted therapies; Temsirolimus

Indexed keywords

SORAFENIB; SUNITINIB; TEMSIROLIMUS;

ADULT; AGED; ANEMIA; ARTICLE; BELLINI COLLECTING DUCT CARCINOMA; CANCER MORTALITY; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; KIDNEY TUMOR; MALE; MOLECULARLY TARGETED THERAPY; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; AGED; BENZENESULFONATES; CARCINOMA, RENAL CELL; FEMALE; HAND-FOOT SYNDROME; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PYRIDINES; PYRROLES; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 84863726660     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0589-3     Document Type: Article

References (15)

1. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol. 1998;15:54-67.
2. Eble JN, Sauter G, Epstein JI, Martignoni G. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press: Lyon; 2004. http://www.iarc.fr/en/ publications/pdfsonline/ pat-gen/bb7/index.php, accessed September 11, 2011.
3. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T. Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan. J Urol. 2006;176:43-9.
4. Dimopoulos MA, Logothetis CJ, Markowitz A, Sella A, Amato R, Ro J. Collecting duct carcinoma of the kidney. Br J Urol. 1993;71:388-91.
5. Matz LR, Latham BI, Fabian VA, Vivian JB. Collecting duct carcinoma of the kidney: A report of three cases and review of the literature. Pathology. 1997;29:354-9.
6. Levin HS, Myles JL. The Pathology of Renal Neoplasms. Renal cell carcinoma: Molecular biology, immunology, and clinical management. 2nd ed. 2009; Totowa: Humana Press. p. 341-406.
7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45: 228-47.
8. Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, Dufour B. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma? J Urol. 2003; 169:1287-90.
9. Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10:1131-41.
10. Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, Neumann RD. Collecting duct carcinoma of the kidney. Hum Pathol. 1990;21:449-56.
11. Rumpelt HJ, Störkel S, Moll R, Schärfe T, Thoenes W. Bellini duct carcinoma: Further evidence for this rare variant of renal cell carcinoma. Histopathology. 1991;18:115-22.
12. Culine S, Oudard S, Duclos B, Banu E, Priou F, Rousseau F, et al. A phase II prospective study of gemcitabine and platin-based combination as first-line chemotherapy for metastatic Bellini duct carcinoma patients. Results of GETUG study. J Clin Oncol. 2005;23:4543.
13. von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol. 2000;18:3068-77.
14. Füzesi L, Cober M, Mittermayer C. Collecting duct carcinoma: Cytogenetic characterization. Histopathology. 1992;21:155-60.
15. Selli C, Amorosi A, Vona G, Sestini R, Travaglini F, Bartoletti R, et al. Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. J Urol. 1997;158:245-7.